Brooksby and Corn hired
New directors to take Neurocentrx global
Nigel Brooksby: new chairman
Neurocentrx, an Edinburgh-based pharmaceutical company, has appointed Nigel Brooksby as non-executive chairman and Dr Tim Corn as non-executive director to take the company to a global market.
Life Sciences entrepreneur Mr Brooksby brings significant experience in business and growth strategy across the healthcare sector.
He has held senior global executive positions at Pfizer, Sanofi and Wellcome (now GSK). He has also worked extensively in private equity and venture capital, and is a past president of the Association of the British Pharmaceutical Association (ABPI).
He brings valuable experience of driving clinical trials to fruition, and will help Neurocentrx bring their innovation to the next level.
Carmel Reilly, CEO of Neurocentrx, said: “I am honoured to welcome the extraordinary experience and talents of Nigel Brooksby and Tim Corn onto the board.
“This is an important milestone for Neurocentrx and marks the start of an exciting new phase of our growth. It is an absolute privilege to work with two such well respected people, who share our vision for the future.”